Medications for Non-Cardiac Chest Pain Caused by Anxiety
For non-cardiac chest pain caused by anxiety, cognitive-behavioral therapy (CBT) is the most effective first-line treatment, but when medications are needed, antidepressants—specifically venlafaxine, sertraline, or imipramine—are recommended over benzodiazepines or SSRIs like paroxetine. 1, 2, 3
Treatment Algorithm
First-Line Approach
The 2021 AHA/ACC guideline emphasizes that patients with non-cardiac chest pain and psychological factors (anxiety, panic disorder) are significantly undertreated, with clinician inquiry rates below 10% despite these conditions being 10-fold more common than coronary artery disease in low-risk chest pain patients 1. The guideline specifically recommends cognitive-behavioral therapy, which demonstrated a 32% reduction in chest pain frequency over 3 months 1.
When Medications Are Indicated
If pharmacologic intervention is necessary, the evidence hierarchy is:
Most Effective Antidepressants:
- Venlafaxine (SNRI): 50% pain reduction vs. 10% placebo (P < 0.001) 2
- Sertraline (SSRI): 63% pain reduction vs. 15% placebo (P = 0.02) 2
- Imipramine (TCA): 52% pain reduction vs. 1% placebo (P = 0.03) 2
Critical Finding: Pain improvement with these medications occurs independent of depression score improvement, meaning they work through pain modulation mechanisms, not just by treating mood 2.
Why NOT Paroxetine
Despite being an SSRI, paroxetine was not more effective than placebo in a head-to-head trial comparing it to CBT 3. This is a crucial distinction—not all SSRIs perform equally for anxiety-related chest pain.
Role of Benzodiazepines
While benzodiazepines reduce anxiety, pain, and cardiovascular activation through GABA amplification and catecholamine reduction 4, they are not recommended as first-line therapy due to:
- Dependence risk (even short-term)
- Higher discontinuation rates (53% vs. 29% placebo) 2
- Lack of guideline support 1, 4
They may have a role for acute symptomatic relief in emergency settings 4, but should not be the primary treatment strategy.
Mechanism of Action
The effectiveness of antidepressants in this context relates to:
- Pain modulation at central nervous system level
- Reduction of heart-focused anxiety (a specific mediator of chest pain) 3
- Addressing visceral hypersensitivity and low pain thresholds 1
CBT works by specifically targeting heart-focused anxiety, which mediates subsequent pain reduction—this is why it outperforms medications 3.
Common Pitfalls to Avoid
Repeated cardiac testing: These patients undergo extensive, repetitive cardiac workups despite negative results, leading to unnecessary radiation exposure (5.0 mSv) and costs 1
Failing to screen for comorbidities: 58% have depression, 57% PTSD, 52% somatization—all treatable conditions that worsen outcomes if ignored 5
Using paroxetine based on "SSRI class effect": Evidence shows paroxetine specifically does not work for this indication 3
Not addressing the psychological component: Only 10% of clinicians inquire about or document psychological factors, representing a "lost opportunity" for effective treatment 1
Practical Implementation
Start with: CBT referral as primary treatment 1, 3
If medication needed: Venlafaxine or sertraline (better tolerated than TCAs) 2, 6
Monitor for: Adverse effects (relatively high compared to placebo, though often not statistically significant) 2
Treatment duration: Minimum 2-3 months to assess response 1, 6
Severe anxiety markers requiring more aggressive intervention include: comorbid depression, low self-efficacy, lower education level, and female sex 5.
The evidence strongly supports that antidepressants have modest but real benefit for non-cardiac chest pain, with venlafaxine and sertraline showing the strongest evidence, but CBT remains superior when available 1, 2, 3.